Oncolytics Biotech Inc. Recorded Big Gain
Tue, Dec 17, 2019 at 05:40 PM
Oncolytics Biotech Inc. (ONCY:NASDAQ) jumped higher at $1.8, representing a gain of 34.3%. On Mon 16 Dec 19, ONCY:NASDAQ hit a New 2-Week High of $1.34. The stock got featured on our News Catalysts scanner on Thu 12 Dec 19 at 07:58 AM in the 'BIOTECH' category. From Mon 25 Nov 19, the stock recorded 42.86% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Oncolytics Biotech Inc. (ONCY:NASDAQ)
Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
Top 10 Gainers:
- Inpixon (INPX:NASDAQ), 100.78%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 34.33%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 31.04%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- 22nd Century Group, Inc. (XXII:NYSEMKT), 28.48%
- Renewable Energy Group, Inc. (REGI:NASDAQ), 26.92%
- Venus Concept Inc. (VERO:NASDAQ), 26.38%
- Precipio, Inc. (PRPO:NASDAQ), 25.97%
- TravelCenters of America Inc. (TA:NASDAQ), 24.5%
- Abraxas Petroleum Corporation (AXAS:NASDAQ), 23.7%